Patient and Physician Perspectives in a Case of Severe Traumatic Brain Injury Rhoderick M. Casis Commentary Open access 10 November 2018 Pages: 171 - 178
Patient Power Revolution in Multiple Sclerosis: Navigating the New Frontier David YeandlePeter RieckmannDawn Langdon Commentary Open access 09 November 2018 Pages: 179 - 187
European and American Guidelines for Multiple Sclerosis Treatment Angelo Ghezzi Commentary Open access 12 October 2018 Pages: 189 - 194
Dibenzazepine Agents in Epilepsy: How Does Eslicarbazepine Acetate Differ? Charlotte LawthomJukka PeltolaVicente Villanueva Commentary Open access 24 September 2018 Pages: 195 - 206
Practical Evidence-Based Recommendations for Patients with Multiple Sclerosis Who Want to Have Children Yara Dadalti FragosoTarso AdoniClaudia Cristina F. Vasconcelos Review Open access 30 August 2018 Pages: 207 - 232
Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia—Key Differences in Pathophysiology and Clinical Management Kristen M. WardLeslie Citrome Review Open access 19 July 2018 Pages: 233 - 248
A Review of Dementia with Lewy Bodies' Impact, Diagnostic Criteria and Treatment Samuel D. CapouchMartin R. FarlowJared R. Brosch Review Open access 09 July 2018 Pages: 249 - 263
Monitoring Progressive Multiple Sclerosis with Novel Imaging Techniques Maria PetraccaMonica MargoniMatilde Inglese Review Open access 28 June 2018 Pages: 265 - 285
A Systematic Review and Meta-Analysis of the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS) Freya CorfieldDawn Langdon Review Open access 19 June 2018 Pages: 287 - 306
Phase 1 Parkinson’s Disease Studies Show the Dopamine D1/D5 Agonist PF-06649751 is Safe and Well Tolerated U. Shivraj SohurDavid L. GrayGang Feng Original Research Open access 25 October 2018 Pages: 307 - 319
Burden of Migraine in Europe Using Self-Reported Digital Diary Data from the Migraine Buddy© Application Pamela VoNicolas ParisFrancois Cadiou Original Research Open access 06 October 2018 Pages: 321 - 332
Decreased Behavioral Abnormalities After Treatment with Combined Donepezil and Yokukansankachimpihange in Alzheimer Disease: An Observational Study. The Osaki-Tajiri Project Kenichi MeguroSatoshi Yamaguchi Original Research Open access 25 September 2018 Pages: 333 - 340
Real-World Observational Evaluation of Hair Thinning in Patients with Multiple Sclerosis Receiving Teriflunomide: Is It an Issue in Clinical Practice? Lori Hendin TravisAnnette OkaiKeith R. Edwards Original Research Open access 06 August 2018 Pages: 341 - 347
Characterizing the High Disease Burden of Transthyretin Amyloidosis for Patients and Caregivers Michelle StewartShannon ShafferWilliam R. Lenderking Original Research Open access 02 August 2018 Pages: 349 - 364
Injection of Onabotulinum Toxin A into the Bilateral External Oblique Muscle Attenuated Camptocormia: A Prospective Open-Label Study in Six Patients with Parkinson’s Disease Hiroyuki TodoHiroshi YamasakiItaru Funakawa Brief Report Open access 09 August 2018 Pages: 365 - 371
Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum Disorders Christine LebrunMikael CohenMichel Ticchioni Case Series Open access 07 June 2018 Pages: 373 - 383
Letter to the Editor Regarding: A Comprehensive Review on Copemyl® Giancarlo ComiFerdinando NicolettiDiego Centonze Letter Open access 10 November 2018 Pages: 385 - 390
Authors’ Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl® Pietro AnnovazziAntonio BertolottoAngelo Ghezzi Letter Open access 10 November 2018 Pages: 391 - 393
Acknowledgement to Authors, Referees, and Readers Marwan N. SabbaghAntonio Bertolotto Acknowledgement Open access 27 November 2018 Pages: 395 - 396